<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="Amantadine" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">livertox</book-id>
    <book-title-group>
      <book-title>LiverTox</book-title>
      <subtitle>Clinical and Research Information on Drug-Induced Liver Injury</subtitle>
    </book-title-group>
    <pub-date date-type="pubr" publication-format="electronic">
      <year>2012</year>
    </pub-date>
    <publisher>
      <publisher-name>National Institute of Diabetes and Digestive and Kidney Diseases</publisher-name>
      <publisher-loc>Bethesda (MD)</publisher-loc>
    </publisher>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">Amantadine</book-part-id>
      <title-group>
        <title>Amantadine</title>
      </title-group>
      <pub-history>
        <date date-type="updated">
          <day>22</day>
          <month>6</month>
          <year>2020</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="livertox">LiverTox: Clinical and Research Information on Drug-Induced Liver Injury</related-object>
      <related-object link-type="previous-part-link" source-id="livertox" document-id="AlzheimersDrugs" document-type="chapter">Alzheimer Disease Agents</related-object>
      <related-object link-type="next-part-link" source-id="livertox" document-id="Ambrisentan" document-type="chapter">Ambrisentan</related-object>
    </book-part-meta>
    <body>
      <sec id="Amantadine.OVERVIEW">
        <title>OVERVIEW</title>
        <sec id="Amantadine.Introduction" sec-type="pubmed-excerpt">
          <title>Introduction</title>
          <p>Amantadine is a primary amine that has both antiviral and dopaminergic activity and is used in the therapy of influenza A and management of Parkinson disease. Amantadine has not been associated with clinically apparent liver injury.</p>
        </sec>
        <sec id="Amantadine.Background">
          <title>Background</title>
          <p>Amantadine (a man' ta deen) is a cyclic primary amine that has antiviral and anti-Parkinsonian activities. The antiviral activity of amantadine is attributed to inhibition of virion uncoating and release of viral RNA in the initial stages of viral replication. Amantadine is active only against influenza A virus and has no activity against influenza B or other upper respiratory viruses. In addition, resistance to amantadine (with cross resistance to rimantadine) can develop rapidly and is now common. The anti-Parkinsonian activity of amantadine appears to be due to its effects on release of dopamine in the substantia nigra. Amantadine is indicated for therapy of influenza A and in management of Parkinson disease and extrapyramidal reactions. Amantadine was approved for use in the United States in 1968 and is currently used both for influenza and Parkinson disease. Amantadine is available as capsules or tablets of 100 mg and as oral syrup generically and under the brand name of Symmetrel. The recommended oral dose for treatment of influenza in adults is 200 mg daily until symptoms have resolved; amantadine can also be administered as prophylaxis as soon as possible after close personal exposure. The dose in Parkinson disease is 100 to 400 mg daily in divided doses. Side effects include anxiety, dizziness, ataxia, confusion, fatigue, headache, insomnia, dry mouth and gastrointestinal upset. Rare potentially severe adverse events include convulsions, depression, suicidal ideation and behavior, acute psychosis, heart failure and hypersensitivity reactions.</p>
        </sec>
        <sec id="Amantadine.Hepatotoxicity">
          <title>Hepatotoxicity</title>
          <p>Despite widespread use, there is little evidence that amantadine when given orally causes liver injury, either in the form of serum enzyme elevations or clinically apparent liver disease.</p>
          <p>Likelihood score: E (unlikely cause of clinically apparent liver injury).</p>
        </sec>
        <sec id="Amantadine.Mechanism_of_Injury">
          <title>Mechanism of Injury</title>
          <p>Amantadine has minimal hepatic metabolism and is excreted largely unchanged in the urine, factors which perhaps explain the absence of significant hepatotoxicity.</p>
          <p>Drug Classes: <related-object link-type="booklink" source-id="livertox" document-id="AntiviralAgents" document-type="chapter">Antiviral Agents</related-object>; <related-object link-type="booklink" source-id="livertox" document-id="AntiparkinsonAgents" document-type="chapter">Antiparkinson Agents</related-object></p>
          <p>Other Drugs in the Class for Influenza: <related-object link-type="booklink" source-id="livertox" document-id="Baloxavir" document-type="chapter">Baloxavir</related-object>, <related-object link-type="booklink" source-id="livertox" document-id="Oseltamivir" document-type="chapter">Oseltamivir</related-object>, <related-object link-type="booklink" source-id="livertox" document-id="Peramivir" document-type="chapter">Peramivir</related-object>, <related-object link-type="booklink" source-id="livertox" document-id="Rimantadine" document-type="chapter">Rimantadine</related-object>, <related-object link-type="booklink" source-id="livertox" document-id="Zanamivir" document-type="chapter">Zanamivir</related-object></p>
        </sec>
      </sec>
      <sec id="Amantadine.PRODUCT_INFORMATION">
        <title>PRODUCT INFORMATION</title>
        <p>
          <bold>REPRESENTATIVE TRADE NAMES</bold>
        </p>
        <p>Amantadine &#x02013; Generic, Symmetrel&#x000ae;</p>
        <p>
          <bold>DRUG CLASS</bold>
        </p>
        <p>Antiviral Agents; Antiparkinson Agents</p>
        <p>
          <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&#x00026;query=Amantadine">COMPLETE LABELING</ext-link>
        </p>
        <p>Product labeling at DailyMed, National Library of Medicine, NIH</p>
      </sec>
      <sec id="Amantadine.CHEMICAL_FORMULA_AND_STRUCTUR">
        <title>CHEMICAL FORMULA AND STRUCTURE</title>
        <table-wrap id="Amantadine.Tc" orientation="portrait" position="anchor">
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_Amantadine.Tc_1_1_1_1" valign="top" align="left" scope="col" rowspan="1" colspan="1">DRUG</th>
                <th id="hd_h_Amantadine.Tc_1_1_1_2" valign="top" align="left" scope="col" rowspan="1" colspan="1">CAS REGISTRY NUMBER</th>
                <th id="hd_h_Amantadine.Tc_1_1_1_3" valign="top" align="left" scope="col" rowspan="1" colspan="1">MOLECULAR FORMULA</th>
                <th id="hd_h_Amantadine.Tc_1_1_1_4" valign="top" align="left" scope="col" rowspan="1" colspan="1">STRUCTURE</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_Amantadine.Tc_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">Amantadine</td>
                <td headers="hd_h_Amantadine.Tc_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pubchem" xlink:href="sid://134978140">768-94-5</ext-link>
                </td>
                <td headers="hd_h_Amantadine.Tc_1_1_1_3" valign="top" align="left" rowspan="1" colspan="1">C10-H17-N</td>
                <td headers="hd_h_Amantadine.Tc_1_1_1_4" valign="top" align="left" rowspan="1" colspan="1">
                  <related-object link-type="ext-image-back-link" source-id="pubchem" document-id="134978140" document-id-type="sid" document-type="summary" object-id="134978140" object-id-type="sid" object-type="image"/>
                </td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec id="Amantadine.ANNOTATED_BIBLIOGRAPHY">
        <title>ANNOTATED BIBLIOGRAPHY</title>
        <p>References updated: 22 June 2020</p>
        <ref-list id="Amantadine.ANNOTATED_BIBLIOGRAPHY.reflist0">
          <ref id="Amantadine.REF.zimmerman.1999">
            <mixed-citation publication-type="book">Zimmerman HJ. Antiviral agents. In, Zimmerman HJ. Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver. 2nd ed. Philadelphia: Lippincott, 1999, pp. 621-3.<annotation><p><italic toggle="yes">(Expert review of antiviral agents and liver injury published in 1999; mentions that both amantadine and rimantadine have "no adverse effect on the liver").</italic></p></annotation></mixed-citation>
          </ref>
          <ref id="Amantadine.REF.n__ez.2013">
            <mixed-citation publication-type="book">N&#x000fa;&#x000f1;ez M. Influenza virus treatments. Hepatic toxicity of antiviral agents. In, Kaplowitz N, DeLeve LD, eds. Drug-induced liver disease. 3rd ed. Amsterdam: Elsevier, 2013, pp. 513.<annotation><p><italic toggle="yes">(Review of hepatotoxicity of antiviral agents; amantadine has been linked to rare instances of liver enzyme elevations).</italic></p></annotation></mixed-citation>
          </ref>
          <ref id="Amantadine.REF.acosta.2018">
            <mixed-citation publication-type="book">Acosta EP. Antiviral agents (nonretroviral). In, Brunton LL, Hilal-Dandan R, Knollman BC, eds. Goodman &#x00026; Gilman's the pharmacological basis of therapeutics. 13th ed. New York: McGraw-Hill, 2018, pp. 1105-18.<annotation><p><italic toggle="yes">(Textbook of pharmacology and therapeutics).</italic></p></annotation></mixed-citation>
          </ref>
          <ref id="Amantadine.REF.schnack.1969.185">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Schnack</surname>
                  <given-names>H</given-names>
                </name>
                <name name-style="western">
                  <surname>Wewalka</surname>
                  <given-names>F</given-names>
                </name>
                <name name-style="western">
                  <surname>Guttmann</surname>
                  <given-names>G</given-names>
                </name>
              </person-group>
              <article-title>Liver function during amantadine hydrochloride medication in compensated liver disease.</article-title>
              <source>Int Z Klin Pharmakol Ther Toxikol</source>
              <year>1969</year>
              <volume>2</volume>
              <fpage>185</fpage>
              <lpage>7</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Placebo controlled trial of 4 weeks of amantadine in 25 patients with cirrhosis showed no difference in ALT, AST, Alk P or bilirubin levels during therapy).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">5800713</pub-id>
            </element-citation>
          </ref>
          <ref id="Amantadine.REF.styrt.1995.839">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Styrt</surname>
                  <given-names>B</given-names>
                </name>
                <name name-style="western">
                  <surname>Freiman</surname>
                  <given-names>JP</given-names>
                </name>
              </person-group>
              <article-title>Hepatotoxicity of antiviral agents.</article-title>
              <source>Gastroenterol Clin North Am</source>
              <year>1995</year>
              <volume>24</volume>
              <fpage>839</fpage>
              <lpage>52</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Review of liver toxicity of antiviral agents mentions that there is little information on the potential hepatotoxicity of amantadine and the product label does not mention liver injury).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">8749901</pub-id>
            </element-citation>
          </ref>
          <ref id="Amantadine.REF.jefferson.2006.cd001169">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Jefferson</surname>
                  <given-names>T</given-names>
                </name>
                <name name-style="western">
                  <surname>Demicheli</surname>
                  <given-names>V</given-names>
                </name>
                <name name-style="western">
                  <surname>Di Pietrantonj</surname>
                  <given-names>C</given-names>
                </name>
                <name name-style="western">
                  <surname>Rivetti</surname>
                  <given-names>D</given-names>
                </name>
              </person-group>
              <article-title>Amantadine and rimantadine for influenza A in adults.</article-title>
              <source>Cochrane Database Syst Rev</source>
              <year>2006</year>
              <issue>2</issue>
              <elocation-id>CD001169</elocation-id>
              <annotation>
                <p>
                  <italic toggle="yes">(Systematic review of efficacy of amantadine and rimantadine in treatment and prevention of influenza A; side effects are frequent, but largely consist of dizziness, insomnia, lightheadedness and headache; no mention of liver tests abnormalities or hepatitis).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">16625539</pub-id>
            </element-citation>
          </ref>
          <ref id="Amantadine.REF.crosby.2003.cd003468">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Crosby</surname>
                  <given-names>N</given-names>
                </name>
                <name name-style="western">
                  <surname>Deane</surname>
                  <given-names>KH</given-names>
                </name>
                <name name-style="western">
                  <surname>Clarke</surname>
                  <given-names>CE</given-names>
                </name>
              </person-group>
              <article-title>Amantadine in Parkinson's disease.</article-title>
              <source>Cochrane Database Syst Rev</source>
              <year>2003</year>
              <issue>1</issue>
              <elocation-id>CD003468</elocation-id>
              <annotation>
                <p>
                  <italic toggle="yes">(Systematic review of efficacy of amantadine in treatment of Parkinson disease; side effects are frequent, but largely consist of dizziness, insomnia, lightheadedness and headache; no mention of liver test abnormalities or hepatitis).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">12535476</pub-id>
            </element-citation>
          </ref>
          <ref id="Amantadine.REF8">
            <element-citation publication-type="journal">
              <article-title>Drugs for non-HIV viral infections.</article-title>
              <source>Treat Guidel Med Lett</source>
              <year>2007</year>
              <volume>5</volume>
              <fpage>59</fpage>
              <lpage>70</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Review of status of non-antiretroviral antiviral agents for prevention and treatment of herpes, varicella-zoster, cytomegalovirus, influenza A and B, and hepatitis B and C; no mention of liver related side effects for amantadine).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">17565338</pub-id>
            </element-citation>
          </ref>
          <ref id="Amantadine.REF.chalasani.2008.1924">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Chalasani</surname>
                  <given-names>N</given-names>
                </name>
                <name name-style="western">
                  <surname>Fontana</surname>
                  <given-names>RJ</given-names>
                </name>
                <name name-style="western">
                  <surname>Bonkovsky</surname>
                  <given-names>HL</given-names>
                </name>
                <name name-style="western">
                  <surname>Watkins</surname>
                  <given-names>PB</given-names>
                </name>
                <name name-style="western">
                  <surname>Davern</surname>
                  <given-names>T</given-names>
                </name>
                <name name-style="western">
                  <surname>Serrano</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>Yang</surname>
                  <given-names>H</given-names>
                </name>
                <name name-style="western">
                  <surname>Rochon</surname>
                  <given-names>J</given-names>
                </name>
                <collab>Drug Induced Liver Injury Network (DILIN)</collab>
              </person-group>
              <article-title>Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.</article-title>
              <source>Gastroenterology</source>
              <year>2008</year>
              <volume>135</volume>
              <fpage>1924</fpage>
              <lpage>34</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Among 300 cases of drug induced liver disease in the US collected between 2004 and 2008; 8 were attributed to antiviral agents but none to amantadine or other antiinfluenza medications).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">18955056</pub-id>
            </element-citation>
          </ref>
          <ref id="Amantadine.REF10">
            <element-citation publication-type="journal">
              <article-title>Antiviral drugs.</article-title>
              <source>Treat Guidel Med Lett</source>
              <year>2013</year>
              <volume>11</volume>
              <issue>127</issue>
              <fpage>19</fpage>
              <lpage>30</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Review of status of non-antiretroviral antiviral agents; because of the high rate of resistance of influenza A virus isolates to amantadine and rimantadine, they are not currently recommended either for prevention or treatment of influenza; no discussion of side effects).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">23459414</pub-id>
            </element-citation>
          </ref>
          <ref id="Amantadine.REF.chalasani.2015.1340">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Chalasani</surname>
                  <given-names>N</given-names>
                </name>
                <name name-style="western">
                  <surname>Bonkovsky</surname>
                  <given-names>HL</given-names>
                </name>
                <name name-style="western">
                  <surname>Fontana</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Lee</surname>
                  <given-names>W</given-names>
                </name>
                <name name-style="western">
                  <surname>Stolz</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Talwalkar</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>Reddy</surname>
                  <given-names>KR</given-names>
                </name>
                <etal/>
                <collab>United States Drug Induced Liver Injury Network</collab>
              </person-group>
              <article-title>Features and outcomes of 899 patients with drug-induced liver injury: The DILIN Prospective Study.</article-title>
              <source>Gastroenterology</source>
              <year>2015</year>
              <volume>148</volume>
              <fpage>1340</fpage>
              <lpage>52.e7</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Among 899 cases of drug induced liver injury enrolled in a US prospective study between 2004 and 2013, no case was attributed to amantadine or any other drug for either Parkinson disease or influenza).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">25754159</pub-id>
            </element-citation>
          </ref>
          <ref id="Amantadine.REF12">
            <element-citation publication-type="journal">
              <article-title>Antiviral drugs for treatment and prophylaxis of seasonal influenza.</article-title>
              <source>Med Lett Drugs Ther</source>
              <year>2019</year>
              <volume>61</volume>
              <issue>1563</issue>
              <fpage>1</fpage>
              <lpage>4</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Concise review of the drug therapy of influenza mentions that there are no data suggesting the superiority of one neuraminidase inhibitor over another, they are all approved for treatment of uncomplicated influenza, should be started as soon as possible, and have been shown to shorten the duration of symptoms by one day in adults; mentions that rimantadine and amantadine are no longer recommended for treatment of influenza because of high rates of resistance in circulating strains of influenza A and they are ineffective against influenza B).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">30681660</pub-id>
            </element-citation>
          </ref>
          <ref id="Amantadine.REF13">
            <element-citation publication-type="journal">
              <article-title>Antiviral drugs for influenza.</article-title>
              <source>Med Lett Drugs Ther</source>
              <year>2020</year>
              <volume>62</volume>
              <issue>1589</issue>
              <fpage>1</fpage>
              <lpage>4</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Concise review of the drug therapy of influenza mentions that there is no evidence that one neuraminidase inhibitor or baloxavir is more effective than any other in treating uncomplicated influenza infections, but that oseltamivir is preferred for treatment of pregnant women, hospitalized patients and those with severe, complicated or progressive illness; mentions that rimantadine and amantadine are no longer recommended for treatment of influenza because of high rates of resistance in circulating strains of influenza A and they are ineffective against influenza B).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">31999661</pub-id>
            </element-citation>
          </ref>
        </ref-list>
      </sec>
      <sec sec-type="link-group" id="Amantadine.OTHER_REFERENCE_LINKS">
        <title>OTHER REFERENCE LINKS</title>
        <list list-type="order">
          <list-item>
            <label>1</label>
            <p>
              <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&#x00026;db=pubmed&#x00026;pubmedfilters=true&#x00026;term=(Amantadine/AE)+AND+Human%5BMH%5D+AND+(drug+induced+liver+injury+OR+jaundice/CI+OR+bile+duct+diseases/CI+OR+liver/DE+OR+liver+diseases/CI)+AND+(%221900/1/1%22%5BEDat%5D:%222999/12/31%22%5BEDat%5D)">Recent References on Amantadine: from PubMed.gov</ext-link>
            </p>
          </list-item>
          <list-item>
            <label>2</label>
            <p>
              <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/results?term=Amantadine">Trials on Amantadine: from ClinicalTrials.gov</ext-link>
            </p>
          </list-item>
        </list>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
